Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-06-23Phase II Study of Intensive Chemotherapy With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin Resistant Germ Cell Tumors
-
CLINICAL_TRIALS study record update · 2016-06-23A Phase I Study of UCN-01 in Combination With Topotecan in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-06-22Phase I Study of Low Dose Whole Abdominal Radiation Therapy (LDWART) in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer With Predominant Non-visceral Abdominal Disease
-
CLINICAL_TRIALS study record update · 2016-06-10Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2016-06-09Cancer Prevention in Women With a BRCA Mutation: A Follow-up Genetic Counselling Intervention
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-06-01Phase II Evaluation of Carboplatin, Paclitaxel and Bevacizumab as First Line Chemotherapy and Consolidation for Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2016-05-25Phase II Randomized Trial of ABT-888 in Combination With Metronomic Oral Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal, Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, or Triple-Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2016-05-24A Cancer Research UK Phase II Proof of Principle Trial of the Activity of the PARP-1 Inhibitor, AG-014699, in Known Carriers of a BRCA 1 or BRCA 2 Mutation With Locally Advanced or Metastatic Breast or Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2016-05-23PHASE I/II TRIAL OF SEQUENTIAL TAXOL/IFOSFAMIDE AND DOSEINTENSIVE CARBOPLATIN/ETOPOSIDE WITH STEM CELL SUPPORT IN CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH UNFAVORABLE PROGNOSTIC FEATURES
-
CLINICAL_TRIALS study record update · 2016-05-23Measurement of the Folate Receptor in Stored Plasma From Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2016-05-18Phase I/II Trial of Sequential Paclitaxel/Ifosfamide Followed by Dose-Escalated, Dose-Intensive Carboplatin, Paclitaxel and Ifosfamide With Stem Cell Support in Cisplatin-Resistant Germ Cell Tumor Patients
-
CLINICAL_TRIALS study record update · 2016-05-18Genomic Signatures of Malignant Germ Cell Tumor Progression: A Retrospective Study of Banked Specimens
-
CLINICAL_TRIALS study record update · 2016-05-17Pilot Study of Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies
-
CLINICAL_TRIALS study record update · 2016-05-13Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
-
CLINICAL_TRIALS study record update · 2016-05-12Gynecological Cancer Survivors' Views on Follow-up After Cancer Treatment
-
CLINICAL_TRIALS study record update · 2016-04-20A Phase II, Double-Blinded, Randomized Evaluation of Femara (Letrozole) Versus Placebo for Adjuvant Treatment After Completion of First-Line Chemotherapy for Patients With Optimally Debulked and Chemoresponsive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2016-04-14Bridging Geographic Barriers: Remote Cancer Genetic Counseling for Rural Women
-
CLINICAL_TRIALS study record update · 2016-04-08A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy
-
CLINICAL_TRIALS study record update · 2016-04-05A Randomized Study of Chemotherapy Versus Hormonal Treatment in Patients With Ovarian Cancer Resistant or Refractory to Platinum and Taxane
-
CLINICAL_TRIALS study record update · 2016-03-30Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
-
CLINICAL_TRIALS study record update · 2016-03-25ClinicalTrials.gov study NCT02719041
-
CLINICAL_TRIALS study record update · 2016-03-25ClinicalTrials.gov study NCT00170664
-
CLINICAL_TRIALS study record update · 2016-03-17A Phase 2, Multi-Center, Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2016-03-17The Genomic, Epigenomic, and Psychosocial Characteristics of Long-Term Survivors of Ovarian Cancer - Recruitment
-
CLINICAL_TRIALS study record update · 2016-03-17A Phase 2, Multi-Center, Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer